AlexanderJulianGillMDPhD(He/Him)

Neuroimmunology/Multiple Sclerosis

Associate Medical Director at Novartis Institutes for BioMedical Research

Dr. Gill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2021 - 2024
University of Pennsylvania Health SystemResidency, Neurology, 2018 - 2021
University of Pennsylvania Health SystemInternship, Internal Medicine, 2017 - 2018
Perelman School of Medicine at the University of PennsylvaniaClass of 2017
University of PennsylvaniaPhD, Neuroscience , 2011 - 2015
Case Western Reserve UniversityB.S./B.S., Biochemistry/Biology , Summa Cum Laude, 2005 - 2009

Neuroscience Research Training Award American Academy of Neurology, 2023
Best Platform Presentation Tykeson Fellows Conference, National Multple Sclerosis Society, 2022
Dichter Translational Research Award University of Pennsylvania, Neurology Residency Program, 2021
American Academy of Neurology Medical Student Prize American Academy of Neurology, 2017
Robert M. Toll Prize For meritorious original research in the field of mental health. University of Pennsylvania., 2015
Neal Nathanson NeuroVirology Lectureship Award International Symposium on NeuroVirology (ISNV), 2013
Join now to see all

PubMed

Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications.
Carson M Quinn, Prashanth Rajarajan, Alexander J Gill, Hannah Kopinsky, Andrew B Wolf
Neurology. 2024-12-10
5 citations
Neurodegeneration and demyelination in multiple sclerosis.
Thomas Garton, Sachin P Gadani, Alexander J Gill, Peter A Calabresi
Neuron. 2024-10-09
16 citations
Emerging imaging and liquid biomarkers in multiple sclerosis.
Alexander J Gill, Emily M Schorr, Sachin P Gadani, Peter A Calabresi
European Journal of Immunology. 2023-08-01

Journal Articles

Retinal optical coherence tomography in MS
Schorr EM, Gill AJ, Saidha S, Calabresi PA, Practical Neurology, 9/2022

Books/Book Chapters

Decision Making in Adult Neurology
Chapter: Paraneoplastic Syndromes
Gill AJEditors: Cucchiara BL, Price RS.Elsevier2020

Targeting NLRX1 to Limit Inflammatory Demyelination and NeurodegenerationAmerican Academy of Neurology2024–2026
Autoantibodies and Neurologic Immune-Related Adverse Events in Immune Checkpoint Inhibitor TherapyPhysicians Scientist Training Program, Johns Hopkins University2022–2024
Targeting Neurotoxic Inflammatory Glia and NLRX1 in MS/EAENational Multiple Sclerosis Society and the American Brain Foundation2021–2024
Heme Oxygenase-1 as a novel therapeutic target in HIV-mediated neurodegenerationNational Institute of Mental Health (NIMH)2014–2017
Training in HIV PathogenesisNational Institute of Allergy and Infectious Diseases (NIAID)2012–2014